Study Compares BBB-Crossing AAV Capsids for Efficient Central Nervous System Delivery
A new study in mice has sharpened one of gene therapy’s most stubborn problems: getting therapeutic genetic material across the ...
A new study in mice has sharpened one of gene therapy’s most stubborn problems: getting therapeutic genetic material across the ...
Dual-target CAR T Cell Therapy Delivered via Cerebrospinal Fluid Elicits Distinct Immune Responses in Recurrent Glioblastoma Recurrent glioblastoma (GBM), a ...
Breast cancer remains one of the most challenging adversaries in oncology, particularly when it advances to the brain, where therapeutic ...
High-grade astrocytoma, including glioblastoma, stands among the most formidable challenges in neuro-oncology due to its aggressive nature and poor prognosis. ...
A pioneering approach spearheaded by researchers at the University of Cincinnati Cancer Center is shedding new light on the formidable ...
In a groundbreaking advancement at the intersection of neuropharmacology and nanotechnology, researchers have unveiled a novel therapeutic strategy targeting the ...
Traumatic brain injury (TBI) stands as one of the most formidable challenges in modern medicine, affecting millions worldwide and often ...
Recent advancements in the field of pharmacology have unveiled a myriad of innovative applications for polyions and polyelectrolyte complexes, particularly ...
In a groundbreaking advancement poised to revolutionize the treatment of neurodegenerative disorders, researchers have unveiled a novel brain-shuttled antibody designed ...
The blood–brain barrier (BBB) has long stood as a formidable obstacle in the treatment of central nervous system (CNS) tumors, ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine